Abstract:Abstract Introduction Arterial thrombosis as a result of plaque rupture or erosion is a crucial event in myocardial infarction and stroke. Oxidative stress and inflammation promote endothelial dysfunction and play a pivotal role in destabilization of the atherosclerotic plaque. Sirtuin 5 (SIRT5) is a member of the sirtuin protein family with function as a NAD+-dependent protein desuccinylase and demalonylase. Being implicated in the regulation of different pathophysiological processes among which production of reactive oxygen species and transcription of inflammatory mediators, SIRT5 plays a role in the development of several cardiovascular diseases such as myocardial infarction and stroke. To date, the possible involvement of SIRT5 as a mediator of arterial thrombosis remains to be investigated. Purpose In this study we investigate the putative role of this protein in arterial thrombosis by using an established in vivo mouse model. The translational value of animal findings as well as the molecular mechanism underlying the observed effect will be investigated also in primary human aortic endothelial cells (HAECs). Methods SIRT5 knockout (KO) as well as SIRT5 transgenic (TG) animals were used for in vivo experiments. HAECs treated with SIRT5 silencing RNA (si-SIRT5) and stimulated with tumor necrosis factor (TNF)-α were used for in vitro assays. Results When compared to WT animals, SIRT5 KO mice display blunted carotid artery thrombus formation as underlined by delayed time to occlusion in a photochemical injury model. Oppositely, in SIRT5 TG mice the formation of an occlusive thrombus is accelerated (Fig 1). Mechanistically, SIRT5 KO and WT animals show no difference in terms of vascular tissue factor (TF) activity, TF concentration in plasma and expression of TF pathway inhibitor (TFPI) in the aorta. In line with the observed reduced thrombogenicity, SIRT5 KO animal express reduced level of the pro-thrombotic plasminogen activator-1 (PAI-1), as assessed by western blot in aorta lysate. Of interest, SIRT5 genetic deletion does not affect platelet aggregation, as assessed by ex-vivo collagen-induced aggregometry. In HAECs, SIRT5-silencing inhibits PAI-1 expression in response to TNF-α. Real-time polymerase chain reaction revealed that inhibition of PAI-1 expression occurs at the mRNA level. This effect is mediated by reduced activation of the MAP kinase Erk 1/2, but not JNK (Fig 1). Conclusions SIRT5 mediates arterial thrombosis by increasing endothelial PAI-1 expression. Hence, SIRT5 may be an effective therapeutic target in the context of atherothrombosis.

2182Sirtuin 5 regulates arterial thrombosis by modulating endothelial plasminogen activator inhibitor-1

SIRT1 and thrombosis

Endogenous SIRT6 in platelets negatively regulates platelet activation and thrombosis

Role of Argininosuccinate Synthase 1 -Dependent L-Arginine Biosynthesis in the Protective Effect of Endothelial Sirtuin 3 Against Atherosclerosis

Abstract 10153: SIRT1 Activation Restores Cardioprotection in the Aged Heart Against Ischemia/Reperfusion Injury

WITHDRAWN: SIRT6 inhibits platelet activation and thrombosis by regulating PCSK9/MAPK signaling

SIRT1 inhibition promotes atherosclerosis through impaired autophagy.

SIRT6 Protects Against Endothelial Dysfunction and Atherosclerosis in Mice

Role of sirtuins in attenuating plaque vulnerability in atherosclerosis

Cardioprotective Role of SIRT5 in Response to Acute Ischemia Through a Novel Liver-Cardiac Crosstalk Mechanism

Sirt6 stabilizes atherosclerosis plaques by promoting macrophage autophagy and reducing contact with endothelial cells

Deletion of Sirtuin 6 Accelerates Endothelial Dysfunction and Atherosclerosis in Apolipoprotein E-Deficient Mice

Sirt1 Acts As A Modulator of Neointima Formation Following Vascular Injury in Mice

SIRT6 Inhibits Inflammatory Response Through Regulation of NRF2 in Vascular Endothelial Cells

SIRT6 Promotes Angiogenesis and Hemorrhage of Carotid Plaque Via Regulating HIF-1α and Reactive Oxygen Species

SIRT1 Inhibits Inflammatory Response Partly Through Regulation of NLRP3 Inflammasome in Vascular Endothelial Cells.

Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice.

Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway

Sirt3 Protects Against Thoracic Aortic Dissection Formation by Reducing Reactive Oxygen Species, Vascular Inflammation, and Apoptosis of Smooth Muscle Cells

Sirtuin 5 is Required for Mouse Survival in Response to Cardiac Pressure Overload

Smooth muscle SIRT1 reprograms endothelial cells to suppress angiogenesis after ischemia